Abhijeet

Abhijeet Kundu
Phone: +917699159024
Website: https://www.linkedin.com/in/abhijeet-kundu-3556421ab
Email: [email protected]
Career Summary
3+ years of research experience in formulation and development of different bioequivalent, cost
effective and scalable formulation.
 Highly adept in formulation and development of different dosage forms like tablets, capsules,
Multiple unit pellet system.
Role Summary 03 Years 02 Months

 Officer I- Formulation Research & development (Medreich R&D Center)
Aug 2020 - Apr 2022
 Officer II- Formulation Research & development (Medreich R&D Center)
Apr 2022 – Feb 2023
 Senior Officer - Formulation Research & development (Sun Pharmaceutical Industries
Limited)
March 2023- Present
Professional Experience
Sun Pharmaceutical Industries Limited 07 Months
 Formulation and development of sustain release tablets of an anti-depressant drug (Canada

market).
 Formulation and development of an immediate release tablets of treating rapidly progressing
ADPKD (US market).
 Formulation and development of an immediate release tablets Macrolide Antibiotics (US market).
 Exposure to various FR&D activities literature search, preparation of literature report, patent
search, application of different licenses, innovator product characterization, identifying of
required materials for product development, exposure on conducting preformulation studies,
optimization of process parameters & formulation parameters by QbD approach, wet granulation
using RMG, dry granulation process, aqueous & non-aqueous tablet coating, wurster coating and
rotor coating, packing and labelling of formulations, stability charging of formulations as per the
respective protocol, preparation of different documents required for pilot and pivotal batches,
preparation of PDR,CDR as per regulatory requirement and involved in bioavailability and
bioequivalence related activities.
Page 1 of 3
Medreich R & D Center (Officer II) 02 Years 06 Months
 Formulation and development of Fixed dose drug combination of an immediate release tablets of
an anti-diabetic drug (EU and Canada Market).
 Formulation and development of Fixed dose drug combination of modified release tablets of an
anti-diabetic drug (Canada Market).
 Formulation and development of an immediate release tablets of an anti-depressant drug (EU
Market).
 Formulation and development of modified release capsules of an anti-anginal drug (EU market).
 Formulation and development of an immediate release tablets of an anti-epileptic drug (EU
market).
 Exposure to various FR&D activities literature search, preparation of literature report, patent
search, application of different licenses, innovator product characterization, identifying of
required materials for product development, exposure on conducting preformulation studies,
optimization of process parameters & formulation parameters by QbD approach, wet granulation
using RMG, dry granulation process, aqueous & non-aqueous tablet coating, wurster coating and
rotor coating, packing and labelling of formulations, stability charging of formulations as per the
respective protocol, preparation of different documents required for pilot and pivotal batches,
preparation of PDR,CDR as per regulatory requirement and involved in bioavailability and
bioequivalence related activities.
Key skills
Software
 Basic knowledge of Microsoft office, Microsoft Excel, Power point.
 Basic knowledge of DD Solver, JMP 17.0, Metis, LIMS 4.0
Instruments handled
 High Shear Mixer Granulator.

 Cadmach CTX compression machine.
 Bilayer compression machine (Eliza EP-200L)
 Roller Compactor
 Capsule filling machine (Pam AFT 25)
 Spray Drying (Labultima)
 Tablet coater
 Multi mill and Unimill
 Fluid bed dryer (Retsch/Bectochem)
 Fluid bed processor/dryer (GPCG1.1)
 IPQC testing instruments
Page 2 of 3
Academic qualification
Course Institute Year Remarks

Dr. B. C. Roy College of Pharmacy &
M. Pharm (Pharmaceutics) 2018-2020 9.73/10.0
A.H.S.
B. Pharm Bengal School of Technology 2013-2017 9.14/10.0
Higher secondary W.B.C.H.S.E 2013 76.20%
Secondary W.B.B.S.E 2011 79.50%
Achievements
 Published review article entitled “Chemistry, Characterization, and Application of
Nanocrystal based Drug Delivery System: Present to future Perspective.
 Secured institutional Gold medal in M.Pharm (Pharmaceutics) of academic year 2018-2020.
 Recognizing by the management, Medreich R&D center, a meiji group company as ‘Star of
the month (Aug 2021)’ for developing and delivering the projects within timeline.
 I have got AIR 1530 in NIPER JEE in 2018
 Qualified Graduate Pharmacy Aptitude Test (GPAT) with AIR 1400 in 2017.
Training
 Training on “QbD & Pharmaceutical Statistics” at Sun Pharmaceutical Industries Limited on
9th August’2023.
 Worked as a trainee and undertook the training entitled ‘Analysis of Pharma Products’ for 15
days in 2019 at the division of food technology, Cytogene Research & Development, Lucknow,
U.P-226016.
 Industrial training in Hygeia Pharmaceuticals Mfg. (P) Ltd. Kolkata-700070, W.B. for 15 days
in 2016.
Personal Information
Date of birth: 12/11/1995
Marital Status: Single
Nationality: Indian
Languages known: English, Hindi, Bengali
Hobbies: Playing cricket, football, volleyball, Social work and cooking.
Permeant Address: Vill-Ganakpara, P.O+P.S-Jiaganj, Murshidabad, West Bengal-742123
Present address: Sivalik Tower, Sreem Shruti Apartment, Sun Pharma Road, Vadodora-390012
Declaration
I hereby declare that the above mentioned information are correct to the best of my knowledge.
Yours Sincerely
Abhijeet Kundu
Page 3 of 3

Abhijeet

Uploaded by

Copyright:

Available Formats

Abhijeet

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Abhijeet

Uploaded by

Copyright:

Available Formats

Abhijeet Kundu

Role Summary 03 Years 02 Months

Sun Pharmaceutical Industries Limited 07 Months

 Formulation and development of sustain release tablets of an anti-depressant drug (Canada

 High Shear Mixer Granulator.

Course Institute Year Remarks

Higher secondary W.B.C.H.S.E 2013 76.20%

Secondary W.B.B.S.E 2011 79.50%

You might also like